Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6606
|
pubmed:dateCreated |
1996-12-13
|
pubmed:abstractText |
Most of the T lymphocytes that populate the immune system develop in the thymus before its involution during late adolescence. Therefore, subsequent losses in T cells caused by HIV infection, chemotherapy or age-related factors can greatly diminish immune responses to new antigenic challenge. Here we report the discovery of a thymus-independent pathway of T-cell development that may provide help for T-cell immunodeficiency. We show that expression of an oncostatin M transgene in the early T lineage stimulates a dramatic accumulation of immature and mature T cells in lymph nodes. A functional thymus is not required for this effect as reconstitution of nu/nu mice with transgenic bone marrow stimulated a 500-fold increase in Thy-1+ lymph node cells and restored immune responsiveness to allogeneic mouse melanoma cells. This lymphopoietic pathway is not unique to transgenic mice because administration of oncostatin M protein produced a similar response in non-transgenic mice. These results identify a new pathway of T-cell development and a potential treatment for T-cell immunodeficiency with oncostatin M.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Growth Substances,
http://linkedlifedata.com/resource/pubmed/chemical/Oncostatin M,
http://linkedlifedata.com/resource/pubmed/chemical/Osm protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0028-0836
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
21
|
pubmed:volume |
384
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
261-3
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8918875-Animals,
pubmed-meshheading:8918875-Bone Marrow Transplantation,
pubmed-meshheading:8918875-Growth Substances,
pubmed-meshheading:8918875-Hematopoiesis, Extramedullary,
pubmed-meshheading:8918875-Immunocompetence,
pubmed-meshheading:8918875-Mice,
pubmed-meshheading:8918875-Mice, Inbred C57BL,
pubmed-meshheading:8918875-Mice, Nude,
pubmed-meshheading:8918875-Mice, Transgenic,
pubmed-meshheading:8918875-Oncostatin M,
pubmed-meshheading:8918875-Peptides,
pubmed-meshheading:8918875-Recombinant Fusion Proteins,
pubmed-meshheading:8918875-T-Lymphocytes,
pubmed-meshheading:8918875-Thymectomy
|
pubmed:year |
1996
|
pubmed:articleTitle |
Regulation of an extrathymic T-cell development pathway by oncostatin M.
|
pubmed:affiliation |
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121, USA. christopher_h._clegg@ccmail.bms.com
|
pubmed:publicationType |
Journal Article
|